Table 1.
COL3A1 mutations in vEDS. The data presented for the different types of mutations is based largely on [10], [37].
Mutation type | Prevalence | Effect on protein | Age at diagnosis | Genotype-phenotype |
---|---|---|---|---|
Glycine mutations | 65% | Collagen III structural abnormality | ∼34 years | Severity is increased with substitution of glycine with larger charged amino acids. Most severe phenotype after splice site mutation |
In frame splice site mutations | 25% | Collagen III structural abnormality | ∼25 years | Most severe phenotype and lowest median age of survival |
Null mutations | 5% | ∼50% Reduction of collagen III | ∼46 years | Mild phenotype and high median age of survival |
Other missense mutations (insertions, deletions, C- and N-terminal mutations etc.) | 5% | Collagen III structural abnormality | ∼45 years | Mild phenotype and high median age of survival |